Oncotarget New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil In non–small cell lung cancer (NSCLC), alterations in the HER2 (ERBB2) gene define a... read more October 8, 2025
Oncotarget Precision Oncology in Metastatic Colorectal Cancer: A Real-World Case Study Heavily pretreated metastatic colorectal cancer (mCRC) poses significant therapeutic challenges."Colorectal cancer is one of... read more September 24, 2025
Oncotarget Immunotherapy Response in Pancreatic Cancer: What a New Study Reveals Identification and analyses of exceptional responders could eventually offer hints as to why PC is... read more September 11, 2025
Oncotarget Amivantamab Monotherapy in Rare EGFR-Mutated Advanced NSCLC Amivantamab, an anti-EGFR/MET bispecific antibody, shows efficacy in EGFR-mutated NSCLC, but its role in... read more August 26, 2025
Oncotarget Cigarette Smoke and Weak DNA Repair: A Double Hit Behind Lung Cancer Risk Lung cancer remains the leading cause of cancer-related fatalities in the United States and worldwide,... read more August 11, 2025
Oncotarget A New Way to Target Resistant Prostate Cancer Cells Currently, there is no effective therapy for CRPC."Prostate cancer is the second most diagnosed... read more July 29, 2025
Oncotarget PRDX1 Identified as Key to Chemotherapy Resistance in Cancer Cells targeting PRDX1 should sensitize tumours to DNA-damaging agents."Scientists have uncovered a promising new strategy... read more July 14, 2025
Oncotarget Immunotherapy Safety for Hepatocellular Carcinoma in Latin America: Insights from a Real-World Study Latin America has been underrepresented in trials evaluating immunotherapy for hepatocellular carcinoma (HCC)."Liver cancer,... read more July 2, 2025
Oncotarget Exploring a Combined Approach: Radiation and Immunotherapy in Bladder Cancer Different treatment strategies are required for the non-muscle-invasive, muscle-invasive, and metastatic stages of bladder cancer."... read more June 16, 2025
Oncotarget Oncotarget Sponsors Open Access Team in 2025 Ride for Roswell Impact Journals, the publisher of Oncotarget, is once again proudly sponsoring the Open Access Team... read more June 10, 2025